Private company
NVN Liquidation, Inc.
American pharmaceutical preparations company, incorporated in Delaware.
Last updated Oct 18, 2026.
Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2022
Where the money goes
Where each dollar of revenue went, fiscal 2022
- Cost of revenue13¢$7.4M
- Research and development27¢$16.0M
- Selling, general and admin58¢$34.1M
- Interest2¢$1.5M
Out of $23.7M in revenue.3 The company lost money this year.
Financial statements
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Revenue | $2.6M4 | $6.0M4 | $4.9M5 | $4.9M6 | $3.0M3 | $23.7M3 | |
| Cost of revenue | $03 | $7.4M3 | |||||
| Research and development | $46.5M7 | $25.2M4 | $23.0M8 | $25.2M5 | $19.8M6 | $20.4M3 | $16.0M3 |
| Selling, general and admin | $12.3M3 | $34.1M3 | |||||
| Operating income | -$59.8M7 | -$35.7M4 | -$28.6M8 | -$30.7M5 | -$30.2M6 | -$29.9M3 | -$34.2M3 |
| Interest | $2.0K12 | $1.0M4 | $1.0M8 | $2.0K5 | $05 | $03 | $1.5M3 |
| Income tax | $07 | $04 | $08 | $05 | $06 | $03 | $03 |
| Net income | -$59.7M7 | -$36.6M4 | -$29.2M8 | -$30.4M5 | -$29.3M6 | -$29.7M3 | -$31.3M3 |
| Earnings per share | -$2.966 | -$1.743 | -$1.423 | ||||
| Earnings per share (diluted) | -$2.966 | -$1.743 | -$1.423 |
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Cash | $34.6M7 | $2.5M4 | $8.2M8 | $13.7M5 | $35.9M6 | $47.1M3 | $12.3M3 |
| Current assets | $35.6M7 | $3.7M4 | $9.3M8 | $15.7M5 | $44.0M6 | $54.1M3 | $42.4M3 |
| Total assets | $52.5M7 | $21.1M4 | $26.4M8 | $29.1M5 | $46.8M6 | $69.0M3 | $90.3M3 |
| Current liabilities | $13.4M7 | $8.9M4 | $9.1M8 | $12.9M5 | $8.7M6 | $11.2M3 | $46.4M3 |
| Long-term debt | $05 | $478.0K6 | $06 | ||||
| Total liabilities | $21.4M7 | $22.9M4 | $19.9M8 | $51.4M5 | $43.9M6 | $50.6M3 | $85.7M3 |
| Shareholders’ equity | $31.1M4 | -$1.7M8 | $6.4M5 | -$22.3M6 | $3.0M3 | $18.3M3 | $4.6M3 |
| Shares outstanding | 15.9M shares7 | 16.0M shares4 | 26.1M shares8 | 26.7M shares5 | 14.6M shares6 | 18.8M shares3 | 24.7M shares3 |
Leadership
Who has led NVN Liquidation, Inc., and when. Pick a name to see everywhere that person has worked.
Chief financial officer
Chief operating officer
- Chief executive officerPaula B. Stafford Feb 4, 2020 to Jan 25, 202213
- Chief executive officerG. Kelly Martin Jun 7, 2017 to Aug 2, 201914
- Chief executive officerNathan Stasko Sep 20, 2016 to Sep 20, 201615
- PresidentPaula B. Stafford Jan 30, 2019 to Jan 25, 202216
- PresidentNathan Stasko Sep 20, 2016 to Feb 23, 201815
- Chief financial officerJohn M. Gay May 19, 2021 to Jun 8, 202317
- Chief financial officerJeff N. Hunter Feb 23, 2018 to Feb 23, 201818
- Chief financial officerWilliam L. Hodges Mar 28, 2017 to Sep 18, 201719
- Chief financial officerRichard D. Peterson Sep 20, 2016 to Sep 20, 201620
- Chief operating officerA. Donofrio John Mar 18, 2022 to Jun 8, 202321
- Chief operating officerPaula B. Stafford Jan 30, 2019 to Sep 10, 201916
Board members and other officers (16)
- VP, Finance & Corp. ControllerJohn M. Gay Jan 31, 2019 to Apr 8, 202022
- Chief Accounting OfficerAndrew Novak Apr 23, 2018 to Jun 9, 202223
- Chief Commercial OfficerBrian M. Johnson Sep 20, 2016 to Jun 14, 201724
- VP of Technical OperationsJeff N. Hunter Sep 20, 2016 to Aug 24, 201825
- Chief Medical OfficerM. Joyce Rico Sep 20, 2016 to Nov 4, 201626
- Board memberSteven D. Skolsky Mar 2, 2021 to Jun 8, 202327
- Board memberJames L. Bierman Sep 25, 2020 to Jun 8, 202328
- Board memberEugene Sun Feb 21, 2018 to Aug 2, 201929
- Board memberPaula B. Stafford Aug 23, 2017 to Jan 25, 202230
- Board memberMachelle Sanders Sep 26, 2017 to Jun 27, 202331
- Board memberG. Kelly Martin Sep 20, 2016 to Aug 2, 201932
- Board memberJohn W. Palmour Sep 20, 2016 to Jun 9, 202233
- Board memberNathan Stasko Sep 20, 2016 to Feb 23, 201815
- Board memberRobert Alexander Ingram Sep 20, 2016 to Jul 30, 202034
- Board memberRobert J. Keegan Sep 20, 2016 to Jun 8, 202335
- Board memberW. Kent Geer Sep 20, 2016 to Jun 8, 202336
Former names
- Novan, Inc.Jul 2, 2009 to Sep 27, 20232
Timeline
Filings
117 filings to the SEC since October 2021: 2 annual reports, 5 quarterly reports, 41 major events, 26 insider forms, 43 other. The latest 20:
- May 1, 2024EFFECT EDGAR
- May 1, 2024EFFECT EDGAR
- May 1, 2024EFFECT EDGAR
- May 1, 2024EFFECT EDGAR
- May 1, 2024EFFECT EDGAR
- May 1, 2024EFFECT EDGAR
- May 1, 2024EFFECT EDGAR
- May 1, 2024EFFECT EDGAR
- May 1, 2024POS AM EDGAR
- May 1, 2024POS AM EDGAR
- May 1, 2024POS AM EDGAR
- May 1, 2024POS AM EDGAR
- May 1, 2024POS AM EDGAR
- May 1, 2024POS AM EDGAR
- May 1, 2024POS AM EDGAR
- May 1, 2024POS AM EDGAR
- May 1, 20248-K EDGAR
- Mar 25, 20248-K EDGAR
- Feb 26, 20248-K EDGAR
- Jan 30, 20248-K EDGAR
The 117 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last three years, summarized. The full record is on SEC EDGAR.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16SEC EDGARPaula B. Stafford, President
- 17SEC EDGARJohn M. Gay, Chief financial officer
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26SEC EDGARM. Joyce Rico, Chief Medical Officer
- 27SEC EDGARSteven D. Skolsky, Board member
- 28SEC EDGARJames L. Bierman, Board member
- 29SEC EDGAREugene Sun, Board member
- 30SEC EDGARPaula B. Stafford, Board member
- 31SEC EDGARMachelle Sanders, Board member
- 32SEC EDGARG. Kelly Martin, Board member
- 33SEC EDGARJohn W. Palmour, Board member
- 34
- 35SEC EDGARRobert J. Keegan, Board member
- 36SEC EDGARW. Kent Geer, Board member